Extended test timing does not help students with ADHD, finds study

Extended test timing does not help students with ADHD, finds study

/0 Comments/in , /by

Many medical experts advocate the need to provide test accommodations, such as extending test timing and offering frequent breaks, for the children affected by attention deficit hyperactivity disorder (ADHD). Recent studies done on them, however, suggest that the extra time offered to the ADHD students in tests may not be very effective in improving their performance or test taking skills.

According to a study, published in Learning Disabilities-A Multidisciplinary Journal, both extended testing time timing or frequent breaks did not help much the students with ADHD in performing better on a standardized test compared to others. One potential reason identified by the researchers could be that the ADHD-affected students lack the understanding of how to effectively utilize such accommodations. Read more →

New anxiety medications in development - Part 3: BNC210

New anxiety medications in development – Part 3: BNC210

/0 Comments/in , , /by

Of the few new and promising anxiety medications under development, BNC210, one of the anxiolytic medicines, has demonstrated a potent anxiolytic effect. Although the trials of this medication are still under way, it has shown efficacy in suppressing the malfunctioning areas of the brain that are responsible for anxiety.

Since it has no addictive or sedative properties, many believe that it can prove to be a better drug in managing anxiety than the current best lorazepam (a benzodiazepine medication). Moreover, it is unlikely to affect the cognitive function due to above characteristics. So far, no major side effect has been reported during the trials. Read more →

New anxiety medications in development - Part 2: B-GOS

New anxiety medications in development – Part 2: B-GOS

/0 Comments/in , /by

According to a study,conducted by Clasado BioSciences Limited in association with the Department of Psychiatry of the University of Oxford, prebiotics Bimuno (B-GOS)may prove to be an ideal antianxiety medication. The findings, published in the journal Psychopharmacology,have revealed that B-GOShas an anxiolytic effect on the users. Consequently, reduced levels of reactivity have been witnessed among people. Read more →

Attachment anxieties in early years can strain relationships

Attachment anxieties in early years can strain relationships

/0 Comments/in , /by

Human beings are social animals; seeking companionship and forming societies are what defines us as a race. Since the dawn of time, humans have been able to attune themselves to those whom they feel connected to and in the process, become dependent upon the relationship.

This need for companionship or for attachment start right from childhood. It is natural that the moment a baby is born, its survival instinct creates a biological need to attach to someone who can provide it with care and comfort. How this need is met has a decisive impact on the interpersonal character of the child as an adult. Lack of attachment during childhood can lead to anxiety that might have detrimental effects on a child, the effects of which can significantly be prevalent during adulthood as well. Read more →